3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
3
Phase 1
3
Phase 2
1
Phase 1/2
1
Status
Not yet recruiting
2
Completed
1
Sponsor Class
OTHER_GOV
3
Study Type
Interventional
3
Sponsor
Cancer Type
Dermatologic
3
Conditions
Multiple Myeloma
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Lymphoma
19
Leukemia, Myeloid, Acute
18
Myelodysplastic Syndromes
17
Lymphoma, Non-Hodgkin
14
Neoplasms, Plasma Cell
12
Leukemia
12
Neuroblastoma
11
Leukemia, Lymphocytic, Chronic, B-Cell
11
Lymphoma, Large B-Cell, Diffuse
9
Hodgkin Disease
9
Recurrence
7
Melanoma
7
Lymphoma, Mantle-Cell
7
Hematologic Neoplasms
7
Burkitt Lymphoma
7
Sarcoma
6
Ovarian Neoplasms
6
Myeloproliferative Disorders
6
Lymphoma, Large-Cell, Immunoblastic
6
Lymphoma, Follicular
6
Sarcoma, Ewing
5
Neoplasm Metastasis
5
Medulloblastoma
5
Lymphoma, B-Cell, Marginal Zone
5
Liver Neoplasms
5
Wilms Tumor
4
Rhabdomyosarcoma
4
Retinoblastoma
4
Interventions
Ipilimumab
10
Nivolumab
9
Interleukin-2
5
Cyclophosphamide
5
pembrolizumab
3
incomplete Freund's adjuvant
3
fludarabine phosphate
3
Radiosurgery
3
Melphalan
3
ADI PEG20
3
sotrastaurin
2
fludarabine
2
Specimen Handling
2
Ranibizumab
2
Magnetic Resonance Spectroscopy
2
MART-1 Antigen
2
CTLA-4 Antigen
2
Biopsy
2
utomilumab
1
tocilizumab
1
siremadlin
1
sargramostim
1
ruxolitinib
1
relatlimab
1
pentetreotide
1
obinutuzumab
1
montanide ISA 51
1
lifileucel
1
gp100 Melanoma Antigen
1
entinostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Phase 1
×
Uveal Melanoma
×
Melphalan
×
Clear all
NCT04812470
2025-09-22
HAITILS
Vastra Gotaland Region
Phase 1
Completed
8 enrolled
NCT07183852
2025-09-19
GoTIL-01
Vastra Gotaland Region
Phase 1
Not yet recruiting
18 enrolled
NCT05903937
2023-06-15
HAITILS-PHP
Vastra Gotaland Region
Phase 1
Not yet recruiting
6 enrolled